Bacterial infections, including surgical site infections (SSI), are a common and serious complication of diabetes. Staphylococcus aureus, which is eliminated mainly by neutrophils, is a major cause of SSI in diabetic patients. However, the precise mechanisms by which diabetes predisposes to staphylococcal infection are not fully elucidated. The effect of insulin on this infection is also not well understood. We therefore investigated the effect of insulin treatment on SSI and neutrophil function in diabetic mice. S. aureus was inoculated into the abdominal muscle in diabetic db/db and high-fat-diet (HFD)-fed mice with or without insulin treatment. Although the diabetic db/db mice developed SSI, insulin treatment ameliorated the infection. db/db mice had neutrophil dysfunction, such as decreased phagocytosis, superoxide production, and killing activity of S. aureus; however, insulin treatment restored these functions. Ex vivo treatment (coincubation) of neutrophils with insulin and euglycemic control by phlorizin suggest that insulin may directly activate neutrophil phagocytic and bactericidal activity independently of its euglycemic effect. However, insulin may indirectly restore superoxide production by neutrophils through its euglycemic effect. HFD-fed mice with mild hyperglycemia also developed more severe SSI by S. aureus than control mice and had impaired neutrophil phagocytic and bactericidal activity, which was improved by insulin treatment. Unlike db/db mice, in HFD mice, superoxide production was increased in neutrophils and subsequently suppressed by insulin treatment. Glycemic control by insulin also normalized the neutrophil superoxide-producing capability in HFD mice. Thus, insulin may restore neutrophil phagocytosis and bactericidal activity, thereby ameliorating SSI.T he number of patients with diabetes mellitus has increased greatly worldwide (8,48). It is well known that diabetic patients are more prone to bacterial infections, including surgical site infections (SSI), than healthy individuals. Although many clinical reports have demonstrated that glycemic control reduces the risk of infections, the precise mechanisms by which diabetes predisposes to infections are not well understood (2, 21, 38). Control of bacterial infections has become more important for diabetic patients than in the past, because of the increase in diabetic patients and their susceptibility to infections. Foot infections following skin ulceration are also common causes of hospitalization for diabetic patients (6). These infectious complications seriously impair prognoses for diabetic patients (44).Gram-positive bacteria cause more than half of cases of diabetesrelated wound infections. Especially, Staphylococcus aureus is a major pathogen in these infections (44). Methicillin-resistant S. aureus (MRSA) also has become prevalent among both nosocomial and community-acquired infections in diabetic patients (44). Neutrophils play crucial roles in eliminating bacteria, including S. aureus, from hosts (22). Therefore, neutrophil ...